We're dedicated to providing safe and effective medicines, alongside services and support for healthy outcomes. This involves superior science, creativity, and collaboration with stakeholders at all levels. As a leading pharma company in the U.S., we focus on devastating diseases and complex medical challenges across six specific therapeutic areas: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
Janssen's grant program aims to improve patient access to treatment and services, advance health equity, and strengthen frontline health workforces within their six key therapeutic areas. Specifically, the program supports disease awareness, patient empowerment and advocacy, linkages to care, and health system improvement with measurable outcomes. For Oncology, the grant focuses on various disease areas including Amyloidosis, Leukemia & Lymphoma, Lung Cancer, Prostate Cancer, Multiple Myeloma, Liposarcoma or Leiomyosarcoma, and Urothelial/Bladder Cancer. Areas of interest include education for patients and caregivers, family/caregiver support, efforts to empower patients and caregivers, tools for therapy assistance, professional and caregiver skill-building, addressing healthcare disparities, addressing work and functionality issues due to illness, direct patient services, disease screenings, outreach, and advocacy for better access to care.
Support will be preferentially directed towards programs and services, rather than requests tied to specific events.